Global X Genomics & Biotechnology UCITS ETF

ISIN IE00BM8R0N95

 | 

WKN A2QRCP

TER
0.50% p.a.
Distribution policy
Accumulating
Replication
Full replication
Fund size
7 m
Holdings
42
 

Overview

Trade this ETF at your broker

Choose your broker
Ad
Broker tip: Trade this ETF for 0.99€ per Order at the Scalable broker or for free in a savings plan. Find out more

Description

The Global X Genomics & Biotechnology UCITS ETF seeks to track the Solactive Genomics index. The Solactive Genomics index tracks companies active in the fields of genomics and biotechnology.
 
The ETF's TER (total expense ratio) amounts to 0.50% p.a.. The Global X Genomics & Biotechnology UCITS ETF is the only ETF that tracks the Solactive Genomics index. The ETF replicates the performance of the underlying index by full replication (buying all the index constituents). The dividends in the ETF are accumulated and reinvested in the ETF.
 
The Global X Genomics & Biotechnology UCITS ETF is a very small ETF with 7m Euro assets under management. The ETF was launched on 2 November 2021 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Index
Solactive Genomics
Investment focus
Equity, World, Health Care
Fund size
EUR 7 m
Total expense ratio
0.50% p.a.
Replication Physical (Full replication)
Legal structure ETF
Strategy risk Long-only
Sustainability No
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in EUR)
27.94%
Inception/ Listing Date 2 November 2021
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Fund Provider Global X
Tax data Bundesanzeiger
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Indextype Total return index
Swap counterparty -
Collateral manager
Securities lending Yes
Securities lending counterparty

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the Global X Genomics & Biotechnology UCITS ETF.
Similar ETFs via ETF search
How do you like our ETF profile? Here you'll find our Questionnaire.

Holdings

Below you find information about the composition of the Global X Genomics & Biotechnology UCITS ETF.

Top 10 Holdings

Weight of top 10 holdings
out of 42
47.44%
Alnylam Pharmaceuticals
6.82%
Avidity Biosciences
5.61%
BioNTech SE
4.86%
Natera
4.86%
Ultragenyx Pharmaceutical, Inc.
4.69%
Veracyte
4.42%
Bio-Techne
4.41%
Myriad Genetics
4.08%
NL0015001WM6
3.90%
Illumina, Inc.
3.79%

Countries

United States
84.43%
Germany
4.86%
Switzerland
3.04%
China
2.72%
Other
4.95%

Sectors

Health Care
96.02%
Other
3.99%
As of 24/09/2024

ETF Savings plan offers

Here you can find information about the savings plan availability of the ETF. You can use the table to compare all savings plan offers for the selected savings rate.
 
Broker Rating Execution fee Account fee
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
Show all offers
Source: justETF Research; As of 11/2024; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of ETF savings plans.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Order fees

Here you can find information about different brokers that allow you to trade ETFs. Select your preferred order volume to compare the fees charged by the respective brokers.
 
Broker Rating Order fee ETF savings plans
0.99€
2593
View offer*
1.00€
2414
View offer*
0.00€
1624
View offer*
0.00€
1087
View offer*
0.00€
897
View offer*
Show all offers
Source: justETF Research; As of 11/2024; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of ETF savings plans.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Performance

Returns overview

YTD -11.92%
1 month -8.96%
3 months -10.84%
6 months -7.28%
1 year -4.55%
3 years -51.42%
5 years -
Since inception (MAX) -52.17%
2023 -11.72%
2022 -32.85%
2021 -
2020 -

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 27.94%
Volatility 3 years 35.19%
Volatility 5 years -
Return per risk 1 year -0.16
Return per risk 3 years -0.61
Return per risk 5 years -
Maximum drawdown 1 year -20.35%
Maximum drawdown 3 years -56.13%
Maximum drawdown 5 years -
Maximum drawdown since inception -57.09%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
Borsa Italiana EUR GNOM -
-
-
-
-
gettex EUR GN0M -
-
-
-
-
Frankfurt Stock Exchange EUR -

GHCO/Virtu
Borsa Italiana EUR -
GNOMEUIV
GNOM.MI
GHCO/Virtu
London Stock Exchange USD GNOM GNOM LN
GNOMUSIV
GNOM.L
GNOMiv.P
GHCO/Virtu
London Stock Exchange GBP GNOG GNOG LN
GNOMGBIV
GNOG.L
GHCO/Virtu
SIX Swiss Exchange CHF GNOM
GNOMCHIV
GNOM.S
GHCO/Virtu
XETRA EUR GN0M
GNOMEUIV
GN0M.DE
GHCO/Virtu

Further information

Further ETFs with similar investment focus

Fund name Fund Size in m € (AuM) TER p.a. Distribution Replication
WisdomTree BioRevolution UCITS ETF USD Acc 3 0.45% p.a. Accumulating Full replication

Frequently asked questions

What is the name of GN0M?

The name of GN0M is Global X Genomics & Biotechnology UCITS ETF.

What is the ticker of Global X Genomics & Biotechnology UCITS ETF?

The primary ticker of Global X Genomics & Biotechnology UCITS ETF is GN0M.

What is the ISIN of Global X Genomics & Biotechnology UCITS ETF?

The ISIN of Global X Genomics & Biotechnology UCITS ETF is IE00BM8R0N95.

What are the costs of Global X Genomics & Biotechnology UCITS ETF?

The total expense ratio (TER) of Global X Genomics & Biotechnology UCITS ETF amounts to 0.50% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is Global X Genomics & Biotechnology UCITS ETF paying dividends?

Global X Genomics & Biotechnology UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of Global X Genomics & Biotechnology UCITS ETF?

The fund size of Global X Genomics & Biotechnology UCITS ETF is 7m Euro. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.